BrainAurora Medical Technology Limited (HKG:6681)

Market Cap	7.07B
Revenue (ttm)	130.16M
Net Income (ttm)	-211.01M
Shares Out	1.27B
EPS (ttm)	-0.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,100,000
Average Volume	712,750
Open	5.54
Previous Close	5.58
Day's Range	5.52 - 5.77
52-Week Range	3.13 - 7.81
Beta	n/a
RSI	22.46
Earnings Date	Jun 26, 2025

About HKG:6681

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; B...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 159
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6681

Financial Performance

In 2024, HKG:6681's revenue was 122.31 million, an increase of 82.01% compared to the previous year's 67.20 million. Losses were -198.28 million, -44.78% less than in 2023.

Financial numbers in CNY